This list is based on the watchlists of people on Stock Events who follow PPCB.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug discovery program. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
The current price of PPCB.BOATS is $0.11 USD — it has increased by +11.55% in the past 24 hours. Watch Propanc Biopharma stock price performance more closely on the chart.
What is Propanc Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Propanc Biopharma stocks are traded under the ticker PPCB.BOATS.
When did Propanc Biopharma complete a stock split?▼
Propanc Biopharma has not had any recent stock splits.